Literature DB >> 12088513

Inulin and oligofructose in the dietary fibre concept.

C Cherbut1.   

Abstract

Dietary fibre consists of remnants of edible plant cell polysaccharides and associated substances resistant to hydrolysis by human alimentary enzymes, which may benefit health through a wide range of physiological effects. Inulin and oligofructose are storage carbohydrates found in a number of vegetables, fruits and whole grains. They resist digestion and absorption in the stomach and small intestine of humans, as shown by their almost full recovery at the end of the ileum of healthy or ileostomised volunteers. Inulin and oligofructose thus enter into the large intestine where they are available to fermentation, as demonstrated by increased breath hydrogen. Fermentation of both substrates is complete and no residue is found in human stools. Inulin and oligofructose improve laxation. Their bulking capacity comprised between 1.2 and 2.1 g of stool per g of ingested substrate, results mainly from increases in microbial biomass in the colon. As water content of bacterial cells is high, stools are softer and easier to expulse. Stool frequency is thus increased, particularly in slightly constipated individuals. In addition, likely due to their fermentation properties, inulin and oligofructose also affect the intestinal epithelium (trophicity, mucin expression, etc.), that may strengthen mucosal protection and reduce the risk of gastrointestinal diseases. In summary, inulin and oligofructose are plant carbohydrates, resistant to digestion in the human small intestine and fermented by colonic bacteria. They exert several intestinal physiological effects contributing to maintenance of health. Therefore, inulin and oligofructose fit well within the current concept of dietary fibre.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088513     DOI: 10.1079/BJNBJN2002532

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  20 in total

1.  Effects of a diet with inulin-enriched pasta on gut peptides and gastric emptying rates in healthy young volunteers.

Authors:  Francesco Russo; Caterina Clemente; Michele Linsalata; Marisa Chiloiro; Antonella Orlando; Emanuele Marconi; Guglielmina Chimienti; Giuseppe Riezzo
Journal:  Eur J Nutr       Date:  2010-10-12       Impact factor: 5.614

Review 2.  Probiotics and prebiotics in chronic inflammatory bowel diseases.

Authors:  Julia B Ewaschuk; Levinus A Dieleman
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

3.  Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose.

Authors:  Gwen Falony; Angeliki Vlachou; Kristof Verbrugghe; Luc De Vuyst
Journal:  Appl Environ Microbiol       Date:  2006-10-20       Impact factor: 4.792

Review 4.  Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.

Authors:  Taekil Eom; Yong Sung Kim; Chang Hwan Choi; Michael J Sadowsky; Tatsuya Unno
Journal:  J Microbiol       Date:  2018-02-28       Impact factor: 3.422

Review 5.  Microbial enzymatic production and applications of short-chain fructooligosaccharides and inulooligosaccharides: recent advances and current perspectives.

Authors:  T Mutanda; M P Mokoena; A O Olaniran; B S Wilhelmi; C G Whiteley
Journal:  J Ind Microbiol Biotechnol       Date:  2014-05-03       Impact factor: 3.346

6.  Effects of Fructo-Oligosaccharide Supplementation on Constipation in Elderly Continuous Ambulatory Peritoneal Dialysis Patients.

Authors:  Kulwara Meksawan; Chorsakon Chaotrakul; Napat Leeaphorn; Suthep Gonlchanvit; Somchai Eiam-Ong; Talerngsak Kanjanabuch
Journal:  Perit Dial Int       Date:  2014-10-07       Impact factor: 1.756

Review 7.  Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis.

Authors:  Matthew J Bull; Nigel T Plummer
Journal:  Integr Med (Encinitas)       Date:  2015-02

Review 8.  Prebiotics in chronic intestinal inflammation.

Authors:  Mirjam A C Looijer-van Langen; Levinus A Dieleman
Journal:  Inflamm Bowel Dis       Date:  2009-03       Impact factor: 5.325

9.  Breath hydrogen produced by ingestion of commercial hydrogen water and milk.

Authors:  Akito Shimouchi; Kazutoshi Nose; Makoto Yamaguchi; Hiroshi Ishiguro; Takaharu Kondo
Journal:  Biomark Insights       Date:  2009-02-09

10.  Gastrointestinal microbiota and some children diseases: a review.

Authors:  Thabata Koester Weber; Isabel Polanco
Journal:  Gastroenterol Res Pract       Date:  2012-10-30       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.